MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced an update to its presentation of certain non-GAAP financial measures. Beginning with its fourth-quarter 2026 financial results, Henry Schein will exclude the gains resulting from the remeasurement to fair value of previously held equity interests from its non-GAAP financial results. These gains arise when the.
Henry Schein (HSIC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in November and December: Jefferies Healthcare Conference at the Waldorf Hilton, London on November 17, 2026, at 9:00 a.m. Greenwich Time/4:00 a.m. Eastern time. Piper Sandler's Healthcare Conference at the Lotte New York Palace Hotel, New York.